Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04888091
Other study ID # 90-07.April.2021
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date June 25, 2021
Est. completion date July 8, 2022

Study information

Verified date February 2024
Source Zeynep Kamil Maternity and Pediatric Research and Training Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

To assess the impact of cervical mucus cleansing before embryo transfer and compare two different instruments for this purpose.


Description:

All patients will be informed about the study and those who give written consent will be included in the study. Women undergoing good quality embryo transfer will be assigned to one of the 3 arms of the study according to the previously determined randomization chart. The first evaluation of the patient will be made on the 12th day after embryo transfer. Pregnancy status will be evaluated with serum βhcg value. If pregnancy is confirmed by serum βhcg value, fetal viability will be evaluated by ultrasound 4 weeks after transfer.


Recruitment information / eligibility

Status Completed
Enrollment 183
Est. completion date July 8, 2022
Est. primary completion date July 8, 2022
Accepts healthy volunteers No
Gender Female
Age group 21 Years to 40 Years
Eligibility Inclusion Criteria: - 21-40 years old women, - Women undergoing good quality embryo transfer, - Women who are eligible for a single or double embryo transfer. Exclusion Criteria: - If there is a diagnosis of a uterine anomaly, - If there is a diagnosis of myoma uteri, - If there is a diagnosis of rheumatological disease, - Women to be transferred other than good quality embryo, - HIstory of previous pelvic, gynecological operation.

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Cotton swab
Removal of the cervical mucus with a cotton swab before embryo transfer.
Cannula
Removal of the cervical mucus with a cannula before embryo transfer.

Locations

Country Name City State
Turkey Zeynep Kamil Women and Children's Diseases Training and Research Hospital Istanbul

Sponsors (1)

Lead Sponsor Collaborator
Zeynep Kamil Maternity and Pediatric Research and Training Hospital

Country where clinical trial is conducted

Turkey, 

Outcome

Type Measure Description Time frame Safety issue
Primary Detecting pregnancy after embryo transfer. Confirmation of pregnancy with serum ßhcg value at the earliest 12th day after embryo transfer. 12 days after embryo transfer/ intervention.
Primary Confirmation of fetal cardiac activity in detected pregnancy. Evaluation of fetal cardiac activity on ultrasound. 3-4 weeks after embryo transfer/ intervention.
Secondary Success of embryo transfer during intervention. In some cases, the embryo is transferred to the endometrial cavity and comes back with the transfer cannula. For this reason, the embryology laboratory checks the transfer cannula after the transfer. If the embryo is still in the embryo transfer cannula, a second attempt is made for embryo transfer. As a secondary outcome, we will evaluate the success in the first attempt for embryo transfer. 5 minutes after embryo transfer.
See also
  Status Clinical Trial Phase
Completed NCT03607409 - Role of Inhibin A as Biomarker for Ovarian Response for IVF Treatment
Recruiting NCT02312076 - GnRHa for Luteal Phase Support in Long GnRHa Protocol Cycles Phase 4
Terminated NCT02161861 - Improvement of IVF Fertilization Rates, by the Cyclic Tripeptide FEE - Prospective Randomized Study N/A
Completed NCT03287479 - Comparison of a Semi-automated Closed Vitrification System (Gavi®) With a Manual Open Vitrification Sytem (Cryotop®) N/A
Terminated NCT03522350 - Randomized Trial Comparing EmbryoScope With EmbryoScope+. N/A
Completed NCT04496284 - Embryo Transfer Outcomes After Vitrification With Slush Nitrogen Compared to Liquid Nitrogen N/A
Completed NCT03623659 - pArtiaL zonA pelluciDa Removal by assisteD hatchINg of Blastocysts N/A
Completed NCT03895099 - New Ovarian Stimulation With Random Start, Use of Progestin Protocol for Oocyte Donors Phase 3
Active, not recruiting NCT04142112 - Randomized, Standard-Controlled, Study to Evaluate the Ohana IVF Sperm Preparation Kit, SPeRtility IVF Next Generation N/A
Completed NCT03152643 - Cumulative Live Birth Rates After Cleavage-stage Versus Blastocyst-stage Embryo Transfer N/A
Recruiting NCT03683771 - Assessment of Endometrial Pattern and Sub-endometrial Vascularity in ICSI Outcome
Recruiting NCT03161119 - Comparing Two Different Embryo Transfer Catheters N/A
Completed NCT04108039 - Micronized Progesterone vs Gonadotropin-releasing Hormone (GnRH) Antagonist in Freeze-all IVF Cycles. N/A
Completed NCT03678571 - Oocyte Vitrification Aided With Latrunculin A N/A
Completed NCT03677492 - Supplementing Intracytoplasmic Sperm Injection Handling Medium With Cytochalasin D ( ICSI-CD) N/A
Completed NCT03678610 - Handling Medium for ICSI With Ionomycin and Latrunculin A N/A
Completed NCT03678584 - Supplementing Intracytoplasmic Sperm Injection Handling Medium With Chaetoglobosin A ( ICSI-CA) N/A
Completed NCT03678597 - Supplementing Intracytoplasmic Sperm Injection Handling Medium With Latrunculin B ( ICSI-LB) N/A
Completed NCT03678558 - Oocyte Vitrification Aided With Cytochalasin B N/A
Completed NCT03678818 - Supplementing Intracytoplasmic Sperm Injection Handling Medium With Latrunculin A (ICSI-LA) N/A